Author Archives: Douglas Johnson, MD, MSCI, Assistant Professor of Medicine & Clinical Director, Melanoma, Vanderbilt-Ingram Cancer Center

Primary category: Melanoma

Profiling Melanoma to Predict Immune Therapy Success

May is Melanoma awareness month, and our series on melanoma continues with a discussion with Dr. Douglas B. Johnson of the Vanderbilt-Ingram Cancer Center. Dr. Johnson leads Vanderbilt’s melanoma clinical and research program, overseeing clinical trials, patient care and translational research. His research interests focus on developing new immune and … (read full article)